Skip to main content
Clinical Trials/NCT04129281
NCT04129281
Recruiting
Not Applicable

Prospective Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma

National Cancer Institute, Naples1 site in 1 country40 target enrollmentJanuary 23, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Papillary Microcarcinoma of the Thyroid
Sponsor
National Cancer Institute, Naples
Enrollment
40
Locations
1
Primary Endpoint
Quality of life in patient who received either surgery or follow up
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The primary objective of this study is to evaluate the outcome of two treatment approaches (immediate surgery or close follow-up) in patients with papillary thyroid microcarcinoma (mPTc) .

Detailed Description

The primary objective of this study is to evaluate the outcome of two treatment approaches (immediate surgery or close follow-up) in patients with papillary thyroid microcarcinoma (mPTc) . A further objective is to identify events associated with high risk of local recurrence and distant metastases. Patients will be randomized to surgery or active surveillance. Patients who refuse the randomization process will be followed according to the treatment choice according to clinical practice.

Registry
clinicaltrials.gov
Start Date
January 23, 2019
End Date
February 23, 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Cancer Institute, Naples
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \>or =18
  • Suspicious nodule \< or = or 13 mm in the maximum size of thyroid ultrasound (not older than 3 months after the screening visit)
  • Cytology consistent with the TIR4 or TIR 5 class
  • Sieric TSH in th standard range (with or without levo-tyroxin therapy)
  • Normal string motility to fibrolaringoscopy
  • Written informed consent

Exclusion Criteria

  • Ultrasound evidence of suspicious lump located on the posterior side of the lobe close to neurogene structures
  • Calcitonin increase above normal levels
  • Clinical or instrumental evidence of locoregional lymph node metastases (central or laterocervical compartment) or remote
  • any Contraindications to surgery

Outcomes

Primary Outcomes

Quality of life in patient who received either surgery or follow up

Time Frame: 36 months

EORTC QLQ-C30, a quality of life questionnaires, composed by 30 items graded from1 (not at all) to 4 (very much) within 1 year from the diagnosis

Secondary Outcomes

  • Quality of life in patient who received either surgery or follow up(36 months)
  • Compare the two strategies in terms of anxiety/depression(36 months)
  • Compare the two strategies in terms of adverse events(36 months)

Study Sites (1)

Loading locations...

Similar Trials